These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 27216181)

  • 1. Noninvasive In Vivo Imaging and Biologic Characterization of Thyroid Tumors by ImmunoPET Targeting of Galectin-3.
    D'Alessandria C; Braesch-Andersen S; Bejo K; Reder S; Blechert B; Schwaiger M; Bartolazzi A
    Cancer Res; 2016 Jun; 76(12):3583-92. PubMed ID: 27216181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galectin-3 Targeting in Thyroid Orthotopic Tumors Opens New Ways to Characterize Thyroid Cancer.
    De Rose F; Braeuer M; Braesch-Andersen S; Otto AM; Steiger K; Reder S; Mall S; Nekolla S; Schwaiger M; Weber WA; Bartolazzi A; D'Alessandria C
    J Nucl Med; 2019 Jun; 60(6):770-776. PubMed ID: 30361380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Chimeric Antigen-Binding Fragment Directed Against Human Galectin-3 and Validation as an Immuno-Positron Emission Tomography Tracer for the Sensitive
    Peplau E; De Rose F; Reder S; Mittelhäuser M; Scafetta G; Schwaiger M; Weber WA; Bartolazzi A; Skerra A; D'Alessandria C
    Thyroid; 2020 Sep; 30(9):1314-1326. PubMed ID: 32200708
    [No Abstract]   [Full Text] [Related]  

  • 4. Galectin-3: The Impact on the Clinical Management of Patients with Thyroid Nodules and Future Perspectives.
    Bartolazzi A; Sciacchitano S; D'Alessandria C
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study.
    Bartolazzi A; Orlandi F; Saggiorato E; Volante M; Arecco F; Rossetto R; Palestini N; Ghigo E; Papotti M; Bussolati G; Martegani MP; Pantellini F; Carpi A; Giovagnoli MR; Monti S; Toscano V; Sciacchitano S; Pennelli GM; Mian C; Pelizzo MR; Rugge M; Troncone G; Palombini L; Chiappetta G; Botti G; Vecchione A; Bellocco R;
    Lancet Oncol; 2008 Jun; 9(6):543-9. PubMed ID: 18495537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid cancer imaging in vivo by targeting the anti-apoptotic molecule galectin-3.
    Bartolazzi A; D'Alessandria C; Parisella MG; Signore A; Del Prete F; Lavra L; Braesch-Andersen S; Massari R; Trotta C; Soluri A; Sciacchitano S; Scopinaro F
    PLoS One; 2008; 3(11):e3768. PubMed ID: 19020658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectin-3 immunodetection in follicular thyroid neoplasms: a prospective study on fine-needle aspiration samples.
    Collet JF; Hurbain I; Prengel C; Utzmann O; Scetbon F; Bernaudin JF; Fajac A
    Br J Cancer; 2005 Nov; 93(10):1175-81. PubMed ID: 16251880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules.
    Abd-El Raouf SM; Ibrahim TR
    Pathol Res Pract; 2014 Dec; 210(12):971-8. PubMed ID: 25041837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective rational humanization of a PASylated anti-galectin-3 Fab for the sensitive PET imaging of thyroid cancer in vivo.
    Peplau E; De Rose F; Eichinger A; Reder S; Mittelhäuser M; Scafetta G; Schwaiger M; Weber WA; Bartolazzi A; D'Alessandria C; Skerra A
    Sci Rep; 2021 Apr; 11(1):7358. PubMed ID: 33795750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galectin-3 and CD44v6 as markers for preoperative diagnosis of thyroid cancer by RT-PCR.
    Samija I; Mateša N; Lukač J; Kusić Z
    Diagn Mol Pathol; 2011 Dec; 20(4):233-41. PubMed ID: 22089351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms.
    Inohara H; Honjo Y; Yoshii T; Akahani S; Yoshida J; Hattori K; Okamoto S; Sawada T; Raz A; Kubo T
    Cancer; 1999 Jun; 85(11):2475-84. PubMed ID: 10357421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methodology and technical requirements of the galectin-3 test for the preoperative characterization of thyroid nodules.
    Bartolazzi A; Bellotti C; Sciacchitano S
    Appl Immunohistochem Mol Morphol; 2012 Jan; 20(1):2-7. PubMed ID: 21691201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules.
    Gasbarri A; Martegani MP; Del Prete F; Lucante T; Natali PG; Bartolazzi A
    J Clin Oncol; 1999 Nov; 17(11):3494-502. PubMed ID: 10550147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond immunohistochemistry and immunocytochemistry: a current perspective on galectin-3 and thyroid cancer.
    Li J; Vasilyeva E; Wiseman SM
    Expert Rev Anticancer Ther; 2019 Dec; 19(12):1017-1027. PubMed ID: 31757172
    [No Abstract]   [Full Text] [Related]  

  • 15. Utility of galectin 3 expression in thyroid aspirates as a diagnostic marker in differentiating benign from malignant thyroid neoplasms.
    Aron M; Kapila K; Verma K
    Indian J Pathol Microbiol; 2006 Jul; 49(3):376-80. PubMed ID: 17001889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hexokinase III, cyclin A and galectin-3 are overexpressed in malignant follicular thyroid nodules.
    Hooft L; van der Veldt AA; Hoekstra OS; Boers M; Molthoff CF; van Diest PJ
    Clin Endocrinol (Oxf); 2008 Feb; 68(2):252-7. PubMed ID: 17868400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic utility of galectin-3 and CD26/DPPIV as preoperative diagnostic markers for thyroid nodules.
    Aratake Y; Umeki K; Kiyoyama K; Hinoura Y; Sato S; Ohno A; Kuribayashi T; Hirai K; Nabeshima K; Kotani T
    Diagn Cytopathol; 2002 Jun; 26(6):366-72. PubMed ID: 12112826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum galectin-1 and galectin-3 levels in benign and malignant nodular thyroid disease.
    Saussez S; Glinoer D; Chantrain G; Pattou F; Carnaille B; André S; Gabius HJ; Laurent G
    Thyroid; 2008 Jul; 18(7):705-12. PubMed ID: 18630998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensity and distribution of immunohistochemical expression of galectin-3 in thyroid neoplasms.
    Matesa-Anić D; Moslavac S; Matesa N; Cupić H; Kusić Z
    Acta Clin Croat; 2012 Jun; 51(2):237-41. PubMed ID: 23115948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms.
    Mehrotra P; Okpokam A; Bouhaidar R; Johnson SJ; Wilson JA; Davies BR; Lennard TW
    Histopathology; 2004 Nov; 45(5):493-500. PubMed ID: 15500653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.